|
DNAJB9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66733293838206E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.65359981052893E-10 |
| Normal-vs-Stage2 |
3.57449999999204E-06 |
| Normal-vs-Stage3 |
2.27562413357418E-12 |
| Normal-vs-Stage4 |
6.28130880642175E-12 |
| Stage1-vs-Stage2 |
9.070600E-01 |
| Stage1-vs-Stage3 |
2.555600E-04 |
| Stage1-vs-Stage4 |
2.559500E-03 |
| Stage2-vs-Stage3 |
9.301400E-03 |
| Stage2-vs-Stage4 |
9.562800E-03 |
| Stage3-vs-Stage4 |
5.390400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47669662556405E-11 |
| Normal-vs-AfricanAmerican |
8.3398999994877E-07 |
| Normal-vs-Asian |
1.81760000383946E-08 |
| Caucasian-vs-AfricanAmerican |
6.510400E-01 |
| Caucasian-vs-Asian |
8.446200E-01 |
| AfricanAmerican-vs-Asian |
6.287800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.41051623106614E-12 |
| Normal-vs-Female |
6.70640210032047E-11 |
| Male-vs-Female |
5.778500E-04 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.92910004321357E-09 |
| Normal-vs-Age(41-60Yrs) |
1.0547118733939E-14 |
| Normal-vs-Age(61-80Yrs) |
6.6729954895095E-12 |
| Normal-vs-Age(81-100Yrs) |
8.079500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.957700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.630400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.200400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.893400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.422600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.089000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.5883999999986E-05 |
| Classical-VS-Follicular |
4.170000E-04 |
| Classical-VS-Other |
4.409200E-01 |
| Classical-VS-Normal |
2.46119791214028E-11 |
| Tall-VS-Follicular |
1.39900000473148E-08 |
| Tall-VS-Other |
3.390000E-01 |
| Tall-VS-Normal |
1.62547753035369E-12 |
| Follicular-VS-Other |
1.172810E-01 |
| Follicular-VS-Normal |
2.757000E-03 |
| Other-VS-Normal |
5.152400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.07209999766766E-08 |
| Normal-vs-N1 |
3.32844862782622E-12 |
| N0-vs-N1 |
1.563800E-03 |
|
|
